The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
ENRYLAZE Jazz Pharmaceuticals ANZ Pty Ltd
Product name
ENRYLAZE
Sponsor
Accepted date
Oct-2023
Active ingredients
crisantaspase
Proposed indication
For treatment of acute lymphoblastic leukaemia and lymphoblastic leukaemia.
Application type
A (new medicine)
Publication date
Oct-2023
Orphan drug
Sponsors receive a fee waiver to help bring medicines for a small population to market.